Imunon, Inc. (IMNN)

Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $10.94 million. The enterprise value is $3.17 million.

Market Cap	10.94M
Enterprise Value	3.17M

Important Dates

The next estimated earnings date is Monday, May 11, 2026, before market open.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Imunon has 3.92 million shares outstanding. The number of shares has increased by 93.23% in one year.

Current Share Class	3.92M
Shares Outstanding	3.92M
Shares Change (YoY)	+93.23%
Shares Change (QoQ)	-0.61%
Owned by Insiders (%)	0.86%
Owned by Institutions (%)	5.70%
Float	3.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.35
P/TBV Ratio	1.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.32, with a Debt / Equity ratio of 0.14.

Current Ratio	2.32
Quick Ratio	1.90
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -256.41% and return on invested capital (ROIC) is -136.12%.

Return on Equity (ROE)	-256.41%
Return on Assets (ROA)	-83.22%
Return on Invested Capital (ROIC)	-136.12%
Return on Capital Employed (ROCE)	-191.16%
Weighted Average Cost of Capital (WACC)	14.57%
Revenue Per Employee	n/a
Profits Per Employee	-$579,801
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.21% in the last 52 weeks. The beta is 2.12, so Imunon's price volatility has been higher than the market average.

Beta (5Y)	2.12
52-Week Price Change	-75.21%
50-Day Moving Average	3.08
200-Day Moving Average	4.47
Relative Strength Index (RSI)	36.86
Average Volume (20 Days)	37,483

Short Selling Information

The latest short interest is 186,889, so 4.76% of the outstanding shares have been sold short.

Short Interest	186,889
Short Previous Month	208,865
Short % of Shares Out	4.76%
Short % of Float	5.28%
Short Ratio (days to cover)	0.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-14.65M
Pretax Income	-14.50M
Net Income	-14.50M
EBITDA	-14.36M
EBIT	-14.65M
Earnings Per Share (EPS)	-$6.83

Balance Sheet

The company has $8.78 million in cash and $1.01 million in debt, with a net cash position of $7.77 million or $1.98 per share.

Cash & Cash Equivalents	8.78M
Total Debt	1.01M
Net Cash	7.77M
Net Cash Per Share	$1.98
Equity (Book Value)	7.06M
Book Value Per Share	2.07
Working Capital	6.10M

Cash Flow

In the last 12 months, operating cash flow was -$13.90 million and capital expenditures -$280,572, giving a free cash flow of -$14.18 million.

Operating Cash Flow	-13.90M
Capital Expenditures	-280,572
Depreciation & Amortization	291,908
Net Borrowing	n/a
Free Cash Flow	-14.18M
FCF Per Share	-$3.61

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-93.23%
Shareholder Yield	-93.23%
Earnings Yield	-132.44%
FCF Yield	-129.54%

Analyst Forecast

The average price target for Imunon is $10.00, which is 252.73% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	252.73%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 7, 2025. It was a forward split with a ratio of 1.15:1.

Last Split Date	Aug 7, 2025
Split Type	Forward
Split Ratio	1.15:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2